INTRODUCTION {#S1}
============

CD8 T cells play an important role in mediating protection against cancer and bacterial, viral, and parasitic infections, and hosts containing memory CD8 T cells are often better protected against tumors or pathogenic re-infection ([@R17]; [@R4]; [@R13]; [@R36]; [@R42]; [@R52]; [@R49]). Therefore, research utilizing laboratory mice has focused on understanding factors influencing memory CD8 T cell generation and characteristics of memory CD8 T cell responses that confer protection against re-infection. This research has led to the understanding that, along with location, size of the memory pool and phenotypic/functional qualities of memory CD8 T cells dictate the level of host protection against re-infection ([@R55]; [@R53]; [@R33]; [@R40]; [@R62]; [@R2]; [@R41]; [@R56], [@R57]; [@R34]; [@R15]; [@R65]). However, the translational value of mouse immunology studies depends on how faithfully those models reflect human immunology, and recent studies have noted areas in which mouse models fail to accurately reflect the human condition. Studies using so-called "dirty mice" have documented that the composition of immune cells present in mice housed in specific-pathogen-free (SPF) facilities is more similar to infants than adult humans and that CD8 T cell responses generated following infection are qualitatively different in SPF mice compared to dirty mice ([@R3]; [@R48]; [@R37]). Similarly, mouse studies, conducted using 1 or 2 strains of inbred mice, fail to fully capture the array of immune responses and outcomes following infection that can be observed in genetically diverse humans ([@R21], [@R22]; [@R18]).

Using a previously described surrogate activation marker approach that can be used to track CD8 T cell responses in any mouse strain ([@R46]), we recently described that (1) the magnitude of effector and memory CD8 T cell responses generated following infection, (2) the rate of phenotypic progression of memory CD8 T cells following infection, and (3) the degree of CD8 T-cell-mediated protection against re-infection vary significantly in genetically unique outbred hosts ([@R35]). Additional studies in humans with experimental vaccination against yellow fever virus have also documented variation in the magnitude of CD8 T cell responses and changes in memory CD8 T cell phenotype and function over time after infection ([@R1]). Taken together, these studies suggest that underlying host genetic factors influence quantitative and qualitative aspects of memory CD8 T cell development following infection, parameters that directly influence the degree of host protection against re-infection. However, due to a lack of tools available in either humans or outbred mice, determining specific genetic factors underlying diverse immune outcomes would be extremely costly and time consuming.

The Collaborative Cross (CC) model circumvents these difficulties and presents an opportunity to examine the biological networks and genetic factors regulating divergent CD8 T cell outcomes following infection in a genetically diverse population. The CC was conceptualized by the complex trait consortium in 2002 as a resource for investigation of biomolecular networks and systems level phenotypes underlying complex traits ([@R7]). CC mice are a recombinant inbred panel of mice derived using a funnel breeding strategy with eight founder strains of mice---5 classical inbred strains (A/J, C57BL/6J, 129S1/SvImJ, non-obese diabetic \[NOD\]/ShiLtJ, and NZO/HILtJ) and 3 wild-derived strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ; [@R60]). Founder strains contain representatives from the three major *Mus musculus* subspecies (*M.m. musculus*, *M.m. domesticus*, and *M.m. castaneous*) and capture almost 90% of the known genetic variation present in laboratory mice originating from *M. musculus*, and the variation is randomly distributed across the genome ([@R59]). Existing CC lines contain millions of single-nucleotide polymorphisms (SNPs) and insertions or deletions (indels) that result in vast genetic diversity between lines. However, progeny within lines are inbred, genetic clones allowing for precise analysis, reproducibility, and comparative studies across different laboratories ([@R44]; [@R8]). Efforts to characterize the genomes of CC strains facilitate the use of genetic analytical tools, such as quantitative trait linking (QTL), that allow for dissection of the genetic factors underlying complex phenotypic traits ([@R8]; [@R58]; [@R23]), such as quantity and quality of memory CD8 T cells generated following infection.

Recent studies utilizing CC mice have documented significant variability in immune subset composition in individual strains at steady state, and QTL analysis was able to link chromosomal regions driving the diverse phenotypes observed ([@R23]; [@R9]). Further studies have analyzed disease outcomes following infection with a spectrum of micro-organisms, including influenza, Ebola, SARS, and West Nile virus ([@R18]; [@R47]; [@R24]; [@R21], [@R22]; [@R16]; [@R31]; [@R30]). Select CC strains captured disease outcomes seen in humans that are not observed in traditional inbred mice, supporting the potential translational value of the CC system. However, thus far, there has been relatively little analysis of the immune response following infection in CC mice that may contribute to differences in disease outcome or of host genetic factors that may underlie potential differences in immune response following infection.

To address this, we analyzed the T cell response following acute lymphocytic choriomeningitis virus (LCMV) Armstrong infection in 47 strains of CC mice. We corroborate previous findings that documented wide diversity in pre-infection immune compartments in CC strains ([@R23]; [@R9]). Importantly, and similarly to what can be observed in individual outbred mice ([@R46]; [@R35]) and in humans ([@R1]), we observed a wide range in magnitude of CD8 T cell responses generated in CC strains following infection. Size of the memory CD8 T cell pool generated correlated with size of the effector CD8 T cell pool, and effector CD8 T cell pool size correlated with levels of systemic cytokines elicited following infection. Subset composition of effector and memory CD8 T cells was also highly variable among CC strains, and rates of memory CD8 T cell phenotypic progression following infection varied among strains to a similar extent to that seen in outbred mice. QTL analysis revealed significant linkages to chromosomal regions associated with the development of CD62L+ memory CD8 T cells following infection and allowed identification of genes potentially driving this phenotype.

Our results support the use of the CC to model diversity in immune responses observed in genetically diverse organisms and to uncover regulatory networks and host genetic factors underlying diverse immune outcomes following infection. This study and future studies utilizing the CC have the potential to improve translational efforts for the generation of vaccines to stimulate protective immune responses against cancer and infections of global importance.

RESULTS {#S2}
=======

Immune Subset Composition prior to Infection Is Variable among CC Strains {#S3}
-------------------------------------------------------------------------

Orchestration of an immune response results from the interplay of cells within innate and adaptive arms of the immune system. Previous studies utilizing the CC have documented differences in immune subset composition among strains at steady state and have identified genetic linkages to observed differences ([@R23]; [@R9]). To corroborate previous studies and to document steady-state immune composition for the 47 CC strains utilized in this study, we bled all mice prior to infection and stained peripheral blood leukocytes (PBLs) using 5 flow cytometry panels to identify CD4 and CD8 T cells, Foxp3+ regulatory CD4 T cells, B220+/CD3− B cells, NKp46+/CD3− natural killer (NK) cells, and SSC^hi^/CD11b^hi^ granulocytes or SSC^lo^/CD11b^hi^ monocytes (example dot plots shown in [Figure S1](#SD1){ref-type="supplementary-material"}). All mice used in this study were female, and CC strains analyzed as well as number of mice analyzed per strain can be found in [Table S1](#SD1){ref-type="supplementary-material"}. We also analyzed commonly used inbred C57BL/6 (B6) and BALB/c strains for comparison. In agreement with previous studies, we found wide variation in representation of immune cell subsets, including CD4 T cells, CD8 T cells, Foxp3+ CD4 T cells, B cells, NK cells, granulocytes, and monocytes, and ratio of CD4 to CD8 T cells at steady state among CC strains examined in this study ([Figures 1A](#F1){ref-type="fig"}--[1H](#F1){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}). Of note, in all cases, subset representation was observed outside of ranges seen between B6 and BALB/c mice. Thus, immune cell composition at steady state among genetically diverse CC strains is variable, suggesting that diverse immune responses may be generated following infection.

Quantitative and Qualitative Aspects of Innate and Adaptive Effector Responses following Infection Are Variable among CC Mice {#S4}
-----------------------------------------------------------------------------------------------------------------------------

Previous studies have described a range of outcomes following infection of collaborative mice that can be observed in the human population but that are not modeled with commonly used inbred mouse strains ([@R21], [@R22]). Additionally, our previous work with outbred mice has shown that quantitative and qualitative aspects of innate and adaptive immune responses following infection are variable among individual, genetically unique mice ([@R46]; [@R35]). However, at present, there has been relatively little analysis of the immune response generated following infection of CC mice. To address this, we infected B6, BALB/c, and CC strains with Armstrong strain of LCMV (LCMV Arm), as the immune response following acute infection with this virus has been well described in B6 and BALB/c mice ([@R66]; [@R29]). Following infection, we analyzed inflammatory cytokines present in serum at day 3 (d3) as a measure of the innate response, weight loss at d8 following infection, and CD4 and CD8 effector responses (CD4 T~eff~ and CD8 T~eff~) at d8 as a measure of the adaptive response ([Figure 2A](#F2){ref-type="fig"}; [Table S3](#SD3){ref-type="supplementary-material"}). Concentrations of interferon (IFN)-α and IFN-γ detected in serum 3 days after infection varied from 30- to 100-fold among strains ([Figure 2B](#F2){ref-type="fig"}), suggesting that the magnitude of innate responses elicited was different among CC strains. Additionally, weight loss 8 days after infection was variable ([Figure 2C](#F2){ref-type="fig"}), suggesting that the infection was experienced differently among strains. We used previously described surrogate activation marker approaches ([@R46]; [@R38]) to detect effector CD4 (CD4 T~eff~) (CD49d^hi^/CD11a^hi^) and CD8 (CD8 T~eff~) (CD11a^hi^/CD8^lo^) responses at d8 (example dot plots shown in [Figure S2](#SD1){ref-type="supplementary-material"}), the peak of the adaptive response in B6 mice following LCMV infection. Magnitudes of CD4 T~eff~ and CD8 T~eff~ responses were strikingly different among strains, with CD4 T~eff~ responses ranging from approximately 10% to over 90% of all CD4 T cells and CD8 T~eff~ responses ranging from approximately 50% to close to 100% of all CD8 T cells ([Figures 2D](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). Because CD8 T cell effector responses have been shown in B6 mice to be influenced by inflammatory cytokines ([@R5]; [@R12]; [@R45]; [@R43]; [@R63]), we determined whether levels of IFN-α and IFN-γ detected in the serum at d3 correlated with CD8 T~eff~ magnitude and found statistically significant correlations for both cytokines ([Figure 2F](#F2){ref-type="fig"}). Thus, the magnitude of innate and adaptive immune responses following infection was correlated within strains but distinct among CC strains.

Effector CD8 T cells can be divided into short-lived effector cells (SLECs) (KLRG1^hi^/CD127^lo^), which are less likely to persist to memory, and memory precursor effector cells (MPECs) (KLRG1^lo^/CD127^hi^), which are more likely to persist to memory, subsets based on expression of phenotypic markers KLRG1 and CD127 ([@R27]; example dot plots shown in [Figure S3](#SD1){ref-type="supplementary-material"}). Wide variation in CD8 T~eff~ subset representation was observed among CC strains ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}; [Table S3](#SD3){ref-type="supplementary-material"}), suggesting that qualitatively different CD8 T~eff~ cells are generated following infection in different strains. Because generation of SLEC and MPEC subsets has been shown to be influenced by aspects of the immune response to infection, including inflammation and CD8 T cell response magnitude ([@R27]), we determined whether representation of SLEC and MPEC subsets could be correlated with other aspects of the immune response. However, we did not find a significant correlation between percentage of SLECs or MPECs and either levels of systemic cytokines elicited or CD8 T~eff~ response magnitude ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}). Taken together, these data suggest that qualitatively and quantitatively different innate and effector immune responses are generated following infection in genetically distinct CC strains.

Size and Phenotype of the Memory CD8 T Cell Pool Generated following Infection Are Highly Variable among CC Mice {#S5}
----------------------------------------------------------------------------------------------------------------

Following contraction, CD4 and CD8 T cells persist as memory cells that are capable of providing the host with increased protection against re-infection. Degree of memory CD8 T-cell-mediated protection against re-infection has been correlated with size of the memory CD8 T cell pool ([@R55]; [@R53], [@R54]), and we previously noted that magnitude of the memory CD8 T cell pool generated following infection is highly variable in outbred mice ([@R46]; [@R35]). Additional studies in humans have documented variation in size of the memory CD8 T cell pool generated in response to experimental vaccination ([@R1]), suggesting that memory CD8 T cell response magnitude is determined at least in part by host genetic makeup. To determine whether memory T cell pools of different sizes are generated in genetically distinct CC strains, we identified memory CD4 (CD4 T~M~) (CD49d^hi^/CD11a^hi^) and CD8 (CD8 T~M~) (CD11a^hi^/CD8^lo^) T cells 75 days after LCMV infection ([Figure 4A](#F4){ref-type="fig"}; [Table S4](#SD4){ref-type="supplementary-material"}; example dot plots shown in [Figure S4](#SD1){ref-type="supplementary-material"}). We found strikingly different sizes of CD4 and CD8 T~M~ cell pools ranging from 1% to 8% (CD4 T~M~) and 1% to 20% (CD8 T~M~) of all lymphocytes in different CC strains ([Figures 4B](#F4){ref-type="fig"}--[4D](#F4){ref-type="fig"}). There was a statistically significant correlation with the size of the memory CD8 T cell pool generated and size of the effector response ([Figure 4E](#F4){ref-type="fig"}), suggesting that the relative size of the memory pool generated could be predicted based on size of the CD8 T~eff~ pool. Thus, T~M~ pools of distinct sizes are generated in genetically diverse CC strains, which could impact degree of memory-mediated protection against re-infection, and the best predictor of CD8 T~M~ cell pool size was size of the CD8 T~eff~ pool generated.

In addition to the number of memory CD8 T cells, their functional abilities (quality) impact degree of memory CD8 T-cell-mediated protection against re-infection ([@R33]; [@R40]; [@R62]; [@R2]; [@R41]; [@R56], [@R57]; [@R65]). Circulating memory CD8 T cells were originally divided into subsets described as T effector memory (Tem), which do not express CD62L, are less proliferative, and more cytotoxic, and T central memory (Tcm), which express CD62L, home to secondary lymphoid organs, are more proliferative, and are better protective against chronic infections ([@R50]; [@R62]). More recently, Tem (Cx3Cr1^hi^/CD27^lo^) and Tcm (Cx3Cr1^lo^/CD27^hi^) subsets have been identified based on expression of Cx3Cr1 and CD27, which allows for identification of an additional memory subset described as peripheral memory (Tpm) (Cx3Cr1^int^/CD27^hi^) that can circulate among peripheral tissues ([@R20]). We and others have shown that the phenotype of memory CD8 T cells in inbred mice changes with time after infection such that the memory pool becomes highly represented by CD62L+ Tcm cells ([@R34]; [@R15]). However, the rate of memory CD8 T cell phenotypic changes was variable in individual outbred mice ([@R35]), suggesting that memory CD8 T cells generated in genetically unique organisms will differ qualitatively and in the ability to provide protection against re-infection.

To determine whether development of phenotypically distinct memory CD8 T cells in CC mice occurs at different rates, we stained T~M~ cells at d75 after infection for expression of Tcm-associated markers CD127, CD62L, and CD27^hi^ and Tem-associated markers KLRG1 and Cx3Cr1 ([Table S4](#SD4){ref-type="supplementary-material"}; example dot plots shown in [Figure S5A](#SD1){ref-type="supplementary-material"}). We also identified Tem (Cx3Cr1^hi^/CD27^lo^), Tpm (Cx3Cr1^int^/CD27^hi^), and Tcm (Cx3Cr1^lo^/CD27^hi^) subsets based on expression of Cx3Cr1 and CD27 ([Table S4](#SD4){ref-type="supplementary-material"}; example dot plots shown in [Figure S5B](#SD1){ref-type="supplementary-material"}). We found that the phenotype of CD8 T~M~ cells at this point following infection could be strikingly different, with some strains possessing as few as 10% or almost 90% of CD8 T~M~ cells expressing Tcm-associated markers and with some strains possessing as few as 10% or as many as 90% of CD8 T~M~ cells expressing Tem-associated markers ([Figure 5A](#F5){ref-type="fig"}). We were unable to find any strong correlations between expression of Tem- or Tcm-associated markers and the magnitude of the effector or memory CD8 T cell populations generated or the levels of systemic cytokines elicited early in the response ([Figure S6](#SD1){ref-type="supplementary-material"}).

We also found that subset representation of memory CD8 T cells was highly variable between strains, ranging from 5% to 80% Tem cells, 0% to 40% Tpm cells, and 5% to 80% Tcm cells ([Figure 5B](#F5){ref-type="fig"}). Expression of CD62L correlated with expression of other Tcm-associated markers CD127 and CD27^hi^, and expression of CD62L was inversely correlated with Tem-associated markers KLRG1 and Cx3Cr1 ([Figure 5C](#F5){ref-type="fig"}), suggesting that expression of CD62L is a good surrogate for true Tcm cells in any host. Interestingly, phenotypic diversity of memory CD8 T cells was greater among CC strains than B6 mice and similar to that seen in individual outbred NIH Swiss mice ([Figure 5D](#F5){ref-type="fig"}), validating use of the CC as a model of diverse CD8 T cell memory outcomes following infection of genetically heterogeneous organisms. Additionally, these data suggest that heritable genetic factors may underlie development of T cell responses of distinct magnitude and/or quality following infection. To determine the heritability of CD4 and CD8 T~eff~ and T~M~ size and phenotypes of CD8 T~eff~ and T~M~ generated following infection that were quantified in [Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, and [5](#F5){ref-type="fig"}, we used a broad sense heritability method to estimate the proportion of total variance contributed by genetic variance. This analysis showed that the genetic contribution was high among all phenotypes examined ([Table S5](#SD5){ref-type="supplementary-material"}), which further suggested that genetic factors may underlie development of T cell responses of distinct magnitude and/or quality following infection.

QTL Mapping Reveals Genetic Associations Influencing Development of CD62L+ CD8 T~M~ Cells {#S6}
-----------------------------------------------------------------------------------------

One of the powerful aspects of the CC model is that it allows for genetic mapping studies to identify genetic factors underlying complex phenotypes. In an attempt to identify gene regions associated with quantitative measurements of the CD8 T cell response to infection, we performed QTL mapping on size of the CD8 T~eff~ response ([Figure 2E](#F2){ref-type="fig"}) and size of the CD8 T~M~ pool generated ([Figure 4C](#F4){ref-type="fig"}). For QTL scans, 1,000 permutations were run, and log of the odds ratio (LOD) scores above the 95^th^ percentile of the distribution were selected as significant QTLs. QTL intervals were then identified based on the LOD scores and effect of founder alleles in Diversity Outbred (DO) mice strains observed at those regions ([@R19]). We did not find significant QTLs associated with size of the CD8 T~eff~ or T~M~ pool (data not shown). However, linear correlation analysis revealed that size of the CD8 T~M~ pool generated correlated with size of the T~M~ pool ([Figure 4E](#F4){ref-type="fig"}) and that size of the T~eff~ pool generated correlated with levels of systemic cytokines elicited early during the response ([Figure 2F](#F2){ref-type="fig"}). This suggests that host factors regulating the innate response to infection may play an important role in determining the magnitude of effector and memory CD8 T cells generated in hosts of diverse genetic backgrounds.

We also performed QTL mapping to show the contribution of each of the founder alleles and identify genes associated with generation of qualitatively distinct memory CD8 T cells based on expression of CD8 T~M~ phenotypic markers ([Figure 5A](#F5){ref-type="fig"}) and CD8 T~M~ subset representation ([Figure 5B](#F5){ref-type="fig"}). Here, we did find significant QTLs associated with development of CD62L+ CD8 T~M~ cells with LOD scores corresponding to p \< 0.05 within chromosome 18 between 60 and 80 Mb-telomere regions and within chromosome 19 between 10 and 20 Mb-telomere regions ([Figure 6A](#F6){ref-type="fig"}). The QTL intervals were determined using the Bayesian credible interval and represents the region most likely to contain the causative polymorphism(s) (<https://www.ncbi.nlm.nih.gov/pubmed/11560912>). Our analysis indicated that QTL regions with max LOD scores explained 61% of variance for generation of CD62L+ CD8 T~M~ cells. Analysis of founder effects did not reveal clear founder effects for QTLs associated with development of CD62L+ CD8 T~M~ cells. However, NOD/ShiLtJ, CAST/EiJ, and NZO/HILtJ haplotypes between 60 and 80 Mb-telomere regions of chromosome 18 were associated with high frequency of CD62L+ CD8 T~M~ cells although inheritance from A/J and PWK/PhJ was associated with low frequency ([Figure 6B](#F6){ref-type="fig"}). Additionally, 129S1/SvImJ and NZO/HILtJ haplotypes between 10 and 20 Mb-telomere regions of chromosome 19 were associated with high frequency of CD62L+ CD8 T~M~ cells although inheritance from A/J, CAST EiJ, and PWK/PhJ was associated with low frequency ([Figure 6B](#F6){ref-type="fig"}). CD62L+ CD8 T cells have classically been described as Tcm cells ([@R50]; [@R62]), but more recent subsetting strategies have also identified Tcm cells as Cx3Cr1^lo^/CD27^hi^ ([@R20]). Using this strategy to subset Tcm cells, we found a trending QTL associated with development of Tcm cells at the same region within chromosome 18 associated with development of CD62L+ T~M~ cells ([Figure 6C](#F6){ref-type="fig"}) that accounted for 50% of variance for generation of Tcm cells, providing further evidence that this chromosomal region is associated with the development of qualitatively distinct Tcm CD8 T cells.

To identify SNPs and the candidate genes that may be driving development of CD62L+ T~M~ cells, we performed association mapping of the QTL interval regions in chromosomes 18 and 19 with SNPs from the DO founder strains using Mouse Genome Project data from the Sanger Institute (<ftp://ftp.jax.org/SNPtools/variants/mgp.v5.merged.snps_all.dbSNP142.vcf.gz>). SNPs with LOD score greater than 3 were selected for the analysis of candidate genes. Further, we surveyed the significant SNPs to see whether those were present only in causal haplotypes or were commonly shared across all haplotypes. Within the QTL region on chromosome 18, we identified 209 SNPs that were shared in all haplotypes ([Figure S7A](#SD1){ref-type="supplementary-material"}; [Table S6](#SD6){ref-type="supplementary-material"}) and determined that SNPs within two candidate genes, *Mbd2* and *Dcc* ([Table 1](#T2){ref-type="table"}), could affect protein structure or function. Of 7 mutations near the gene region encoding for *Mbd2*, 3 were intronic, 2 were upstream, and 2 were downstream of the gene, although all SNPs associated with *Dcc* were intronic. SNPs identified in chromosome 19 QTL regions were present only in the haplotypes A/J, CAST/EiJ, and PWK/PhJ, which were associated with low-fre quency CD62L+ CD8 T~M~ cells ([Figure S7B](#SD1){ref-type="supplementary-material"}; [Table S7](#SD7){ref-type="supplementary-material"}). Candidate genes within the QTL regions of chromosome 19 that contained missense mutations included *Ms4a3*, *Patl1*, *Gm22272*, *Olfr235*, *Olfr1434*, *Olfr1436*, and *Pfpl* ([Table 1](#T2){ref-type="table"}). Therefore, we have been able to characterize diverse adaptive immune responses within the CC reflective of outbred mice and the human population and identify gene regions and candidate genes driving this diversity. This further validates the usefulness of the CC as a translatable model that can identify complex interactions underlying unique immune responses following infection.

DISCUSSION {#S7}
==========

Previous studies have demonstrated the translational value of the collaborative cross due to its ability to model variation in immune cell composition and function at steady state and reveal disease outcomes observed in humans, but not in traditionally used inbred mouse strains ([@R21], [@R22], [@R23]; [@R9]; [@R16]; [@R18]; [@R24]; [@R30]; [@R31]; [@R47]). These studies have also demonstrated the power of the CC as a tool to identify genetic factors underlying complex traits by using QTL mapping to identify gene regions and gene candidates driving differences in immune cell composition at steady state. Here, we further advance the utility of the CC by providing detailed analysis of the immune response following acute virus infection in 47 strains of CC mice. We corroborate previous findings of variation in immune subset composition among strains at steady state. Additionally, we describe wide variation in the magnitude of cytokines elicited during the adaptive immune response, size of the effector and memory T cell response, and phenotype and subset representation of effector and memory CD8 T cells generated following infection. This variation is similar to that seen in outbred mice ([@R46]; [@R35]) and that can be observed in the human population ([@R1]) but that is not reflected in inbred B6 and BALB/c mice. We were also able to identify factors underlying qualitative and quantitative differences in the immune response following infection. Using linear correlation analysis, we demonstrate that magnitude of the memory CD8 T cell pool generated correlates with size of the effector pool generated and that effector pool size is correlated with levels of systemic cytokines elicited during the innate response. We also performed QTL mapping to identify gene regions and candidate genes driving the generation of CD62L+ Tcm CD8 T cells.

Size of the memory CD8 T cell pool has been correlated with host ability to provide protection against re-infection ([@R55]; [@R53], [@R54]). Consequently, immunologists have sought to determine factors influencing size of the CD8 T cell pool generated following infection and have demonstrated that inflammation can affect CD8 T cell response magnitude ([@R5]; [@R12]; [@R45]; [@R43]; [@R63]). Here, we have shown that the degree of inflammation elicited during the innate immune response to infection correlated with magnitude of the effector CD8 T cell response and that size of the effector response was a good predictor of memory CD8 T cell pool size. Importantly, levels of inflammation elicited during the innate response differed among CC strains. This suggests that the CC could be used to dissect factors influencing generation of inflammatory cytokines by cells of the innate arm of the immune system and how this impacts generation of memory CD8 T cells in genetically diverse organisms. Exploration of this kind could lead to improved knowledge of ways to improve the adaptive immune response following infection and/or vaccination in order to increase size of the memory CD8 T cell pool generated in hosts that do not generate sufficiently robust innate and/or adaptive immune responses.

In addition to memory CD8 T cell pool size, quality of memory CD8 T cells, which encompasses functional abilities that are different among phenotypically distinct subsets of memory CD8 T cells, influences protective capacity ([@R33]; [@R40]; [@R62]; [@R2]; [@R41]; [@R56], [@R57]; [@R65]). We found that phenotype and subset representation of memory CD8 T cells generated differed among collaborative cross strains, suggesting that qualitatively different memory CD8 T cells are generated within strains. CD62L+ Tcm cells are highly proliferative, become the dominant subset within the memory pool with time after infection, and provide enhanced protection compared to Tem cells following chronic viral infection ([@R50]; [@R62]; [@R34]; [@R15]). Through mapping analysis, we identified QTLs within chromosomes 18 and 19 and several candidate genes within these regions underlying the generation of CD62L+ memory CD8 T cells ([Figure 6](#F6){ref-type="fig"}; [Table 1](#T2){ref-type="table"}). Genes listed in [Table 1](#T2){ref-type="table"} require further studies to determine whether and how their products may regulate development of CD62L+ memory as well as their mode of action. These genes could be acting intrinsically within CD8 T cells to influence development of CD62L+ memory CD8 T cells. However, *Mbd2* is known to impact function of antigen-presenting cells and differentiation of CD4 T cells ([@R10]; [@R26]), suggesting that genes of interest may act extrinsically by modulating function of other cell types that regulate priming of CD8 T cells and/or the cytokine milieu during the response. Therefore,examination of the impact of these genes of interest on development of CD62L+ Tcm cells will need to include careful analysis of CD8 T cells themselves as well as other cell types that may impact CD8 T cell differentiation.

In this study, we focused primarily on CD8 T cells found in circulation, but additional immune cell types shape the primary and memory-mediated responses to infection. Our analysis of the CD4 T cell response indicated that representation of CD4 T cells and of regulatory CD4 T cells at steady state differed among strains, as did magnitude of effector and memory CD4 T cell responses following infection. CD4 T cells differentiate into functionally distinct subsets following infection ([@R14]), and differences in CD4 T cell differentiation following infection among strains, which was not examined here, have the potential to shape the inflammatory environment and to influence the development of CD8 T cell and B cell responses ([@R28]; [@R11]). Furthermore, in addition to Tem, Tpm, and Tcm cells found in the circulation, memory CD8 T cells can persist as tissue resident memory (Trm) cells that provide protection against infections originating at barrier tissues ([@R33]; [@R56]; [@R51]). Trm cells differentiate from phenotypically and transcriptionally unique precursor cells within the circulation ([@R32]), and data here that describe the generation of phenotypically distinct effector CD8 T cells among collaborative cross strains following LCMV infection suggest that strains may differ in their ability to form Trm populations. Therefore, the CC may be useful for modeling development of qualitatively unique adaptive immune responses following infection and for identification of factors driving differentiation of distinct B cell and CD4 and CD8 T cell subsets.

Research utilizing the CC has examined disease outcomes following infection with pathogens of human interest, including influenza, Ebola, SARS, and West Nile virus ([@R18]; [@R47]; [@R24]; [@R21], [@R22]; [@R16]; [@R31]; [@R30]), but little in- depth analysis of how underlying differences in immune responses influence divergent disease outcomes has been conducted. Our analysis of responses following LCMV Armstrong infection described here can serve as a blueprint for examination of immune responses following infection with additional pathogens of human interest, including those that cause localized and/or chronic infections.

As is the case with all experimental science, the study that we describe here does possess limitations that will be important to examine in future studies. Due to the number of mice required for this study, and because there is a limited amount of tissue that can be collected from a mouse for cellular analysis and the need to keep mice alive for an extended period of time to examine memory T cell responses, all CC strains in this study received the same infectious dose of virus and T cell responses were all analyzed at the same effector time point, which has been described as the peak of the response in B6 mice. Differences in kinetics and magnitude of early viral infection and clearance are known to affect the magnitude of T cell responses, and we were unable to determine whether there were differences in the course of infection among CC strains. Future studies should determine this and what role any differences in initial infection have on the CD8 T cell response. Additionally, because the CC strains possess different major histocompatibility complex (MHC) haplotypes, we were unable to analyze T cell responses of known epitope specificity. Future studies should examine T cell responses against bona fide epitopes, but this may require generation of recombinant inbred cross (RIX) lines that contain fixed MHC haplotypes capable of generating T cells recognizing known epitopes, such as the well-studied CD8 T cell response to the GP~33~ epitope of LCMV. Additionally, differences in memory CD8 T cell response quantity and quality observed in this study suggest that CC strains may possess a differential ability to provide protection against secondary infection. This was not examined in this study but will be important to follow up on in future studies. However, this examination may also require adjustments to the model, as secondary LCMV infection is rapidly cleared due to the magnitude of the primary response. In this case, RIX mice may also be useful, as it would allow secondary infection with recombinant bacteria that have been engineered to express epitopes present in the organism used for the primary infection. Lastly, as was previously mentioned in the discussion, it will be important to isolate and test candidate genes driving generation of memory CD8 T cells of distinct quality identified in this study.

In summary, we have advanced the utility of the CC as a tool to study the immune response to infection in a model that reflects diversity of responses seen in the human population. We have shown how the CC can reveal genetic factors influencing generation of qualitatively and quantitatively distinct adaptive immune responses following infection. Selection of CC strains with unique responses following acute, systemic infection revealed in this study may prove valuable in understanding factors regulating generation of memory CD8 T cells of unique phenotypes required to provide protection against infection with pathogens of human interest.

STAR★METHODS {#S9}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S11}
---------------------------------------

Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Vladimir Badovinac (<vladimir-badovinac@uiowa.edu>). This study did not generate unique reagents.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

Inbred female C57BL/6 and BALB/c mice were purchased from the National Cancer Institute (Frederick, MD) and bred at the University of Iowa. Outbred female NIH Swiss mice were obtained from Charles River Laboratories. Female CC mice were obtained from the Systems Genetics Core Facility at the University of North Carolina, Chapel Hill (Keane, \#79) ([@R61]). Prior to their relocation to UNC, CC lines were generated and bred at Tel Aviv University in Israel ([@R25]), Geniad in Australia ([@R39]), and Oak Ridge National Laboratory in the United States ([@R6]). All mice were housed at the University of Iowa under specific pathogen-free conditions at the appropriate biosafety level and used at 6--20 weeks of age. All animal experiments were approved by the IACUC of the University of Iowa and met stipulations of the *Guide for Care and Use of Laboratory Animals* (National Institutes of Health.

METHOD DETAILS {#S13}
--------------

### Infections {#S14}

All LCMV Armstrong infections were performed intraperitoneally with 2×10^5^ plaque forming units per mouse. All mice were weighed prior to infection and on d8 post infection.

### Flow Cytometry {#S15}

Prior to infection and at indicated days post infection, blood was collected and red blood cells were lysed with ACK. Prior to infection, cells were stained for surface expression of CD8, CD4, CD11a, and CD49d; CD3, NKp46, Ly49H, and CD122; CD11b, CD11c, and Gr1; or CD3 and B220; or for surface expression of CD4 and intracellular expression of Foxp3 using Foxp3 staining kit protocols (eBioscience). Following infection, cells were stained for surface expression of CD8, CD4, CD11a, CD49d, and PD1; CD8, CD11a, KLRG1, and CD127; CD8, CD11a, CD62L, and CD27; or CD8, CD11a, Cx3Cr1, and CD27. Ag-experienced CD4 T cells were detected based on increased expression of CD11a and CD49d as previously described ([@R38]). Ag-experienced CD8 T cells were detected based on increased expression of CD11a and decreased expression of CD8 as previously described ([@R46]). Short-lived effector cells (SLECs- KLRG1^hi^/CD127^lo^) and memory precursor effector cells (MPECs- KLRG1^lo^/CD127^hi^) were detected on d8 post infection based on expression of KLRG1 and CD127 as previously described ([@R27]). Effector memory (T~em~ - Cx3Cr1^hi^/CD27^lo^), peripheral memory (T~pm~- Cx3Cr1/CD27^hi^), and central memory (T~cm~ - Cx3Cr1^lo^/CD27^hi^) CD8 T cells were detected on d75 post infection based on expression of Cx3Cr1 and CD27 as previously described ([@R20]).

### ELISAs {#S16}

Blood was collected from mice at d3 post infection and serum was separated and collected by centrifugation of samples at 13,300x*g* for 3 minutes. IFN-α was measured using a mouse IFN-a platinum ELISA kit (eBioscience). For detection of IFN-γ, purified IFN-γ mAb (eBioscience) was diluted to 2 μg/mL and 50 μL/well was added to a flat bottom 96 well MaxiSorp ELISA plate and incubated overnight at 4°C. The following day, the plate was washed with PBS/Tween, and 200 μL/well of RP10 was added and plates were incubated at room temperature for 2 hours. Plates were then washed with PBS/Tween, and 25 μL of serum sample was added to wells along with 25 μL of PBS, and standards were prepared and plated with a range of 156.2--80,000 pg/mL, and plates were incubated overnight at 4°C. The following day, plates were washed with PBS/Tween. Biotinylated anti-IFN-γ detecting mAb (eBioscience) was diluted to 1 μg/mL in PBS, and 100 μL was added per well, and plates were incubated at room temperature for 2 hours. Plates were then washed with PBS/Tween. Avidin-peroxidase was diluted to 2.5 μg/mL in PBS, and 100 μL was added per well and plates were incubated at room temperature for 30 minutes. Plates were then washed with PBS/Tween. 100 μL of TMB substrate containing 0.2 μL/mL of hydrogen peroxide was added per well and plates were incubated for 10 minutes at room temperature. The reaction was then stopped by adding 25 μL/well of 2 M sulfuric acid. Absorbance values (450 nM) were measured and assessed for all plates using Gen5 software (BioTek).

### QTL Mapping {#S17}

QTL mapping was performed with select phenotypes observed as CD8 T cell response to infection. Phenotype data were imported into the R software environment (<http://www.r-project.org>) and DOQTL version 1.19.0 Bioconductor package ([@R19]) was used for mapping. 1000 permutations were run for QTL scans. Genotype markers in the CC mice were obtained from the Jackson Laboratory (<ftp://ftp.jax.org/MUGA/muga_snps>) and the haplotype probabilities from the Systems Genetics Core Facility at the University of North Carolina, Chapel Hill (Keane, \#79). DOQTL implements regression analysis to calculate Log of the odds ratio (LOD) score comparing the phenotype observations with and without the founder genotype probabilities at each locus ([@R19]). The statistical significance of LOD scores is determined via a permutation test and the genomic loci with scores above the threshold *p* value of 0.05 were selected as associated QTLs with founder effects. The most likely causative SNPs and genes in significantly associated QTL regions were determined by mapping the with range of SNPs in the Sanger Mouse Genomes obtained from the Jackson Laboratory (<ftp://ftp.jax.org/SNPtools/variants/mgp.v5.merged.snps_all.dbSNP142.vcf.gz>). SNPs with potential effect on protein function or gene regulation were selected as higher-priority candidate genes.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S18}
---------------------------------------

Data for summary graphs are presented as mean values ± SEM. For violin plots, black dots indicate collaborative cross strains with highest and lowest percentages and red dots indicate percentage in B6 mice. Dashed lines at 25^th^ and 75^th^ quartiles and median. *R*-squared values and statistical significance were calculated from linear regression analysis using GraphPad Prism software version 8 (GraphPad Software Inc., San Diego, CA). Broad sense heritability method was used to estimate the proportion of genetic variance that contributed to total variance of observed parameters ([@R64]). LOD values for QTL mapping were determined using DOQTL version 1.19.0 Biocunductor package ([@R19]), and statistical significance of LOD scores was determined by a permutation test where genomic loci with scores above the threshold *p* value of 0.05 were selected as associated with QTLs with founder effects.

DATA AND CODE AVAILABILITY {#S19}
--------------------------

The accession number for unproccessed FACS Files pertaining to [Figures 1](#F1){ref-type="fig"}--[5](#F5){ref-type="fig"} and raw QTL mapping pertaining to [Figure 6](#F6){ref-type="fig"} are available at Mendeley Data <https://dx.doi.org/10.17632/r7gfn2brw4.1>.
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![CC Mice Display Variation in Immune Subset Composition prior to Infection\
Summary graphs (left) and violin plots (right) of the percentage of CD4 (A) and CD8 (B) T cells out of total lymphocytes, ratio of CD4 to CD8 T cells (C), Foxp3+ cells of gated CD4 T cells (D), B cells (E), NK cells (F), granulocytes (G), and monocytes (H) out of total lymphocytes for uninfected B6 (red), BALB/c (blue), and CC (Hotchkiss, no. 22) strains. Data are from 1--3 individual experiments. n = 1--20 mice per group (see [Table S1](#SD1){ref-type="supplementary-material"}). Error bars for summary graphs indicate standard error of the mean and dashed red lines at percentage seen in B6 mice. For violin plots, black dots indicate collaborative cross strains with highest and lowest percentages and red dots indicate percentage in B6 mice. Dashed lines at 25^th^ and 75^th^ quartiles and median are shown. See also [Figure S1](#SD1){ref-type="supplementary-material"} and [Table S2](#SD2){ref-type="supplementary-material"}.](nihms-1584942-f0002){#F1}

![Magnitude of Innate and Adaptive CD4 and CD8 T Cell Responses Is Variable in CC Strains\
(A) Experimental design. B6, BALB/c, and CC mice were infected with LCMV-Armstrong on d0. Concentration of IFN-a and IFN-g in serum was determined on d3, and weight loss and effector T cell (T~eff~) responses were determined on d8. (B) Summary graphs (left) and violin plots (right) of concentration of IFN-α (top) and IFN-γ (bottom) detected in serum. (C) Summary graphs (left) and violin plots (right) of % starting weight (weight at d8 divided by weight at d0). (D) Summary graphs (left) and violin plots (right) of percentage of CD4 T~eff~ cells (CD49d^hi^/CD11a^hi^) out of total lymphocytes (top) or gated CD4 T cells (bottom). (E) Summary graphs (left) and violin plots (right) of percentage of CD8 T~eff~ cells (CD11a^hi^/CD8a^lo^) out of total lymphocytes (top) or gated CD8 T cells (bottom). (F) Percentage of T~eff~ CD8 T cells out of total lymphocytes (x axis) relative to concentration of IFN-a (top) or IFN-g (bottom) detected in serum (y axis).\
Data from 1--3 individual experiments. n = 1--20 mice per group (see [Table S1](#SD1){ref-type="supplementary-material"}). Error bars for summary graphs indicate standard error of the mean and dashed red lines at percentage seen in B6 mice. For violin plots, black dots indicate CC strains with highest and lowest percentages and red dots indicate percentage in B6 mice. Dashed lines at 25^th^ and 75^th^ quartiles and median are shown. For linear correlations, red dots indicate B6 mice, blue dots indicate BALB/c mice, and black dots indicate CC strains. Statistical significance of R-squared values based on linear regression analysis is shown. See also [Figure S2](#SD1){ref-type="supplementary-material"} and [Table S3](#SD3){ref-type="supplementary-material"}.](nihms-1584942-f0003){#F2}

![Representation of Effector CD8 T Cell Subsets Generated following Infection Is Variable in CC Strains\
(A) Experimental design. B6, BALB/c, and CC mice were infected with LCMV-Armstrong on d0. Phenotype of T~eff~ cells (CD11a^hi^/CD8a^lo^) was determined on d8. (B) Summary graphs (left) and violin plots (right) of percentage of CD8 T~eff~ cells displaying a short-lived effector cell (SLEC) (KLRG1^hi^/CD127^lo^; top) or memory precursor effector cell (MPEC) (KLRG1^lo^/CD127^hi^; bottom) phenotype. (C) Percentage of SLECs (left 2 graphs) out of CD8 T~eff~ cells (x axis) relative to concentration of IFN-α (left) or IFN-γ (right) detected in serum (y axis) or percentage of MPECs (right 2 graphs) out of CD8 T~eff~ cells (x axis) relative to concentration of IFN-α (left) or IFN-γ (right) detected in serum (y axis). (D) Percentage of SLECs (left) or MPECs (right) out of CD8 T~eff~ cells relative to percentage of CD8 T~eff~ cells out of total lymphocytes (x axis).\
Data from 1--3 individual experiments. n = 1--20 mice per group (see [Table S1](#SD1){ref-type="supplementary-material"}). Error bars for summary plots indicate standard error of the mean and dashed red lines at percentage seen in B6 mice. For violin plots, black dots indicate CC strains with highest and lowest percentages and red dots indicate percentage in B6 mice. Dashed lines at 25^th^ and 75^th^ quartiles and median are shown. For linear correlations, red dots indicate B6 mice, blue dots indicate BALB/c mice, and black dots indicate CC strains. R-squared values were all not significant based on linear regression analysis. See also [Figure S3](#SD1){ref-type="supplementary-material"} and [Table S3](#SD3){ref-type="supplementary-material"}.](nihms-1584942-f0004){#F3}

![Magnitude of Memory CD4 and CD8 T Cell Responses Is Variable in CC Mice\
(A) Experimental design. B6, BALB/c, and CC mice were infected with LCMV-Armstrong on d0. Memory T cell (T~M~) responses and % contraction of CD8 T cells (% of d75 T~M~/% of d8 T~Eff~) were determined on d75. (B) Summary graphs (left) and violin plots (right) of percentage of CD4 T~M~ cells (CD49d^hi^/CD11a^hi^) out of total lymphocytes (top) or gated CD4 T cells (bottom). (C) Summary graphs (left) and violin plots (right) of percentage of CD8 T~M~ cells (CD11a^hi^/CD8a^lo^) out of total lymphocytes (top) or gated CD8 T cells (bottom). (D) Summary graphs (left) and violin plots (right) of percent contraction of CD8 T cell responses. (E) Percentage of CD8 T~eff~ cells (d8) out of total lymphocytes (x axis) relative to percentage of CD8 T~M~ cells (d75) out of total lymphocytes (y axis).\
Data from 1--3 individual experiments. n = 2--20 mice per group (see [Table S1](#SD1){ref-type="supplementary-material"}). Error bars for summary plots indicate standard error of the mean and dashed red lines at percentage seen in B6 mice. For violin plots, black dots indicate CC strains with highest and lowest percentages and red dots indicate percentage in B6 mice. Dashed lines at 25^th^ and 75^th^ quartiles and median are shown. For linear correlations, red dots indicate B6 mice, blue dots indicate BALB/c mice, and black dots indicate CC strains. Statistical significance of R-squared values based on linear regression analysis is shown. See also [Figure S4](#SD1){ref-type="supplementary-material"} and [Table S4](#SD4){ref-type="supplementary-material"}.](nihms-1584942-f0005){#F4}

![Phenotype of Memory CD8 T Cells Generated following Infection Is Diverse in CC Strains\
B6, BALB/c, and CC mice were infected with LCMV-Armstrong on d0. Phenotype of T~M~ cells (CD11a^hi^/CD8a^lo^) was determined on d75. (A) Summary graphs of percentage of CD8 T~M~ cells expressing CD127, CD62L, CD27^hi^, KLRG1, or Cx3Cr1. (B) Summary graphs of percentage of CD8 T~M~ cells displaying an effector memory (T~em~) (Cx3Cr1^hi^/CD27^lo^; top), peripheral memory (T~pm~) (Cx3Cr1^int^/CD27^hi^; middle), or central memory (T~cm~) (Cx3Cr1^lo^/CD27^hi^; bottom) phenotype. (C) Percentage of CD8 T~M~ cells (d75) expressing CD62L (x axis) relative to percentage expressing CD127, CD27^hi^, KLRG1, or Cx3Cr1 (y axis). (D) B6, NIH Swiss (SW), and CC mice were infected with LCMV-Armstrong on d0. Phenotype of T~M~ cells (CD11a^hi^/CD8a^lo^) was determined on d75+. Violin plots of the percentage of T~M~ cells expressing CD127, CD62L, CD27^hi^, and KLRG1 for B6 or SW mice or CC strains are shown.\
Data from 1--3 individual experiments. n = 2--20 mice per group (see [Table 1](#T2){ref-type="table"}). Error bars for summary plots indicate standard error of the mean and dashed red lines at percentage seen in B6 mice. For linear correlations, red dots indicate B6 mice, blue dots indicate BALB/c mice, and black dots indicate CC strains. Statistical significance of R-squared values based on linear regression analysis. For violin plots, solid lines are at the 25^th^ and 75^th^ quartiles and dashed line indicates the median. See also [Figures S5](#SD1){ref-type="supplementary-material"} and [S6](#SD1){ref-type="supplementary-material"} and [Table S4](#SD4){ref-type="supplementary-material"}.](nihms-1584942-f0006){#F5}

![Significant QTLs within Chromo somes 18 and 19 Drive the Frequency of CD62L+ CD8 T~M~ Cells\
(A) QTL analysis for chromosomal regions associated with frequency of CD62L+ CD8 T~M~ cells. Significant QTLs were found within chromosome 18 at position 60--80 Mb and within chromosome 19 at position 10--20 Mb. (B) Analysis of founder effects associated with the significant QTL within chromosome 18 revealed a correlation with inheritance from NOD/ShiLtJ, CAST/EiJ, and NZO/HILtJ and high frequency of CD62L+ CD8 T~M~ cells and inheritance from A/J and PWK/PhJ with low frequency of CD62L+ CD8 T~M~ cells (top). Analysis of founder effects associated with the significant QTL within chromosome 19 revealed a correlation with inheritance from 129S1/SvImJ and NZO/HILtJ with high frequency of CD62L+ CD8 T~M~ cells and inheritance from A/J, CAST EiJ, and PWK/PhJ with low frequency of CD62L+ CD8 T~M~ cells (bottom). (C) QTL analysis for chromosomal regions associated with Tcm (Cx3Cr1^lo^/CD27^hi^) CD8 T~M~ subset representation revealed a trending QTL at the same region within chromosome 18, driving frequency of CD62L+ CD8 T~M~ cells.\
Data from 1--3 individual experiments. In (A) and (C), the solid red line indicates the threshold for an LOD score with p \< 0.05. See also [Figure S7](#SD1){ref-type="supplementary-material"} and [Tables S5](#SD5){ref-type="supplementary-material"}, [S6](#SD6){ref-type="supplementary-material"}, and [S7](#SD7){ref-type="supplementary-material"}.](nihms-1584942-f0007){#F6}

###### 

Candidate Genes Driving Observed Phenotypes

  Phenotype         OTL Region          Founder Effects                      Candidate Genes in Region
  ----------------- ------------------- ------------------------------------ ------------------------------------------------------------
  CD62L+ CD8 T~M~   Chr 18: 60--80 MB   NOD, CAST, WSB high A/J, PWK low     *Mbd2, Dcc*
                    Chr 19: 10--20 MB   129S1, NZO high A/J, CAST, PWK low   *Ms4a3, Patll, Gm22272, Olfr235, Olfr1434, Olfr1436, Pfpl*

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                    SOURCE                                                     IDENTIFIER
  ------------------------------------------------------ ---------------------------------------------------------- ----------------------------------------------------------------------------------------------------------
  Antibodies                                                                                                        
  Anti-mouse CD8α (53--6.7) PerCP-Cy5.5                  eBioscience                                                Cat \# 45-0081-82; RRID:AB_1107004
  Anti-mouse CD8α (53--6.7) APC-Cy7                      Biolegend                                                  Cat \# 100714; RRID:AB_312753
  Anti-mouse CD8α (53--6.7) APC                          eBioscience                                                Cat \#17-0081-82; RRID:AB_469335
  Anti-mouse CD4 (GK1.5) APC                             eBioscience                                                Cat \# 17-0041-82; RRID:AB_469320
  Anti-mouse CD11a (M17/4) FITC                          Biolegend                                                  Cat\# 101106; RRID:AB_312779
  Anti-mouse CD49d (R1--2) PE                            eBioscience                                                Cat \# 12-0492-82; RRID:AB_465697
  Anti-mouse CD3 (145--2C11) PerCP-Cy5.5                 eBioscience                                                Cat \# 45-0031-82; RRID:AB_1107000
  Anti-mouse NKp46 (29A1.4) FITC                         Biolegend                                                  Cat \# 137606; RRID:AB_2298210
  Anti-mouse Ly49H (3D10) APC                            eBioscience                                                Cat \# 14-5886-82; RRID:AB_906245
  Anti-mouse CD122 (5H4) PE                              eBioscience                                                Cat \# 12-1221-82; RRID:AB_465833
  Anti-mouse CD11b (M17/0) FITC                          eBioscience                                                Cat \#11-0112-82; RRID:AB_464935
  Anti-mouse CD11c (N418) PE                             eBioscience                                                Cat \# 12-0114-82; RRID:AB_465552
  Anti-mouse Gr1 (RB6--8C5) APC                          eBioscience                                                Cat \# 17-5931-82; RRID:AB_469476
  Anti-mouse B220 (RA3--6B2) APC                         eBioscience                                                Cat \# 17-0452-82; RRID:AB_469395
  Anti-mouse Foxp3 (FJK-16S) PE                          eBioscience                                                Cat \# 12-5773-82; RRID:AB_465936
  Anti-mouse PD1 (J43) PerCP-eF710                       eBioscience                                                Cat \# 46-9985-82; RRID:AB_11150055
  Anti-mouse KLRG1 (2F1) APC                             eBioscience                                                Cat \# 17-5893-82; RRID:AB_469469
  Anti-mouse CD127 (A7R34) PE                            eBioscience                                                Cat \# 12-1271-82; RRID:AB_465844
  Anti-mouse CD62L (MEL-14) APC-eF780                    eBioscience                                                Cat \# 47-0621-82; RRID:AB_1603256
  Anti-mouse CD62L (MEL-14) APC                          eBioscience                                                Cat \# 17-0621-82; RRID:AB_469410
  Anti-mouse CD27 (LG.7F9) PE                            eBioscience                                                Cat \# 12-0271-82; RRID:AB_465614
  Anti-mouse Cx3Cr1 (SA011F11) PerCP-Cy5.5               Biolegend                                                  Cat\# 149010; RRID:AB_2564494
  IFN gamma monoclonal antibody (R4--6A2) unconjugated   eBioscience                                                Cat \# MM701; RRID:AB_223538
  IFN gamma monoclonal antibody (XMG1.2) Biotin          eBioscience                                                Cat \# MM700; RRID:AB_223608
  Bacterial and Virus Strains                                                                                       
  LCMV-Armstrong                                         Badovinac Lab                                              NA
  Critical Commercial Assays                                                                                        
  Mouse IFN alpha Platinum ELISA 96 tests Kit            eBioscience                                                Cat \#: BMS6027; RRID:AB_2575643
  Deposited Data                                                                                                    
  Unprocessed FACS Files and raw QTL mapping             Mendeley Data                                              <https://dx.doi.org/10.17632/r7gfn2brw4.1>
  Experimental Models: Organisms/Strains                                                                            
  Mouse: C57BL/6J                                        National Cancer Institute                                  \#556
  Mouse: BALB/c                                          National Cancer Institute                                  \#555
  Mouse: Swiss Webster (CFW)                             Charles River                                              \#550
  Mouse: CC003/UNC                                       University of North Carolina                               IMSR Cat\# UNC102; RRID:IMSR_UNC:102
  Mouse: CC002/UNC                                       University of North Carolina                               IMSR Cat \# UNC44; RRID:IMSR_UNC:44
  Mouse: CC019/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:114; RRID:IMSR_UNC:114
  Mouse: CC037/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:159; RRID:IMSR_UNC:159
  Mouse: CC001/UNC                                       University of North Carolina                               IMSR Cat\# UNC:28; RRID:IMSR_UNC:28
  Mouse: CC041/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:140; RRID:IMSR_UNC:140
  Mouse: CC068/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:163; RRID:IMSR_UNC:163
  Mouse: CC055/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:154; RRID:IMSR_UNC:154
  Mouse: CC006/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:123; RRID:IMSR_UNC:123
  Mouse: CC071/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:167; RRID:IMSR_UNC:167
  Mouse: CC051/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:138; RRID:IMSR_UNC:138
  Mouse: CC041/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:140; RRID:IMSR_UNC:140
  Mouse: CC011/UNC                                       University of North Carolina                               IMSR Cat\# UNC:11; RRID:IMSR_UNC:11
  Mouse: CC057/UNC                                       University of North Carolina                               IMSR Cat\# UNC:155; RRID:IMSR_UNC:155
  Mouse: CC036/UNC                                       University of North Carolina                               IMSR Cat\# UNC:131; RRID:IMSR_UNC:131
  Mouse: CC035/UNC                                       University of North Carolina                               IMSR Cat\# UNC:143; RRID:IMSR_UNC:143
  Mouse: CC023/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:122; RRID:IMSR_UNC:122
  Mouse: CC053/UNC                                       University of North Carolina                               IMSR Cat\# UNC:149; RRID:IMSR_UNC:149
  Mouse: CC031/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:96; RRID:IMSR_UNC:96
  Mouse: CC008/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:94; RRID:IMSR_UNC:94
  Mouse: CC032/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:31; RRID:IMSR_UNC:31
  Mouse: CC030/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:25; RRID:IMSR_UNC:25
  Mouse: CC025/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:126; RRID:IMSR_UNC:126
  Mouse: CC012/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:127; RRID:IMSR_UNC:127
  Mouse: CC027/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:152; RRID:IMSR_UNC:152
  Mouse: CC079/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:172; RRID:IMSR_UNC:172
  Mouse: CC065/UNC                                       University of North Carolina                               IMSR Cat\# UNC:42; RRID:IMSR_UNC:42
  Mouse: CC072/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:119; RRID:IMSR_UNC:119
  Mouse: CC004/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:16; RRID:IMSR_UNC:16
  Mouse: CC005/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:15; RRID:IMSR_UNC:15
  Mouse: CC059/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:153; RRID:IMSR_UNC:153
  Mouse: CC013/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:108; RRID:IMSR_UNC:108
  Mouse: CC015/UNC                                       University of North Carolina                               IMSR Cat\# UNC:10; RRID:IMSR_UNC:10
  Mouse: CC024/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:125; RRID:IMSR_UNC:125
  Mouse: CC017/UNC                                       University of North Carolina                               IMSR Cat\# UNC:112; RRID:IMSR_UNC:112
  Mouse: CC021/UNC                                       University of North Carolina                               IMSR Cat\# UNC:117; RRID:IMSR_UNC:117
  Mouse: CC046/UNC                                       University of North Carolina                               IMSR Cat\# UNC:156; RRID:IMSR_UNC:156
  Mouse: CC056/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:134; RRID:IMSR_UNC:134
  Mouse: CC043/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:35; RRID:IMSR_UNC:35
  Mouse: CC044/UNC                                       University of North Carolina                               IMSR Cat\# UNC:158; RRID:IMSR_UNC:158
  Mouse: CC050/UNC                                       University of North Carolina                               IMSR Cat\# UNC:3; RRID:IMSR_UNC:3
  Mouse: CC052/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:151; RRID:IMSR_UNC:151
  Mouse: CC058/UNC                                       University of North Carolina                               IMSR Cat\# UNC:168; RRID:IMSR_UNC:168
  Mouse: CC060/UNC                                       University of North Carolina                               IMSR Cat\# UNC:165; RRID:IMSR_UNC:165
  Mouse: CC061/GENIUNC                                   University of North Carolina                               IMSR Cat\# UNC:137; RRID:IMSR_UNC:137
  Mouse: CC063/UNC                                       University of North Carolina                               IMSR Cat\# UNC:141; RRID:IMSR_UNC:141
  Mouse: CC078/TAUUNC                                    University of North Carolina                               IMSR Cat\# UNC:171; RRID:IMSR_UNC:171
  Software and Algorithms                                                                                           
  FACSCanto                                              BD Biosciences                                             <https://www.bdbiosciences.com/en-us>
  Gen5 microplate reader and imager software             BioTek                                                     <https://www.biotek.com/products/software-robotics-software/gen5-microplate-reader-and-imager-software/>
  R software environment                                 The R Project for Statistical Computing                    <https://www.r-project.org/>
  DOQTL version 1.19.0 Bioconductor package              Daniel Gatti, Karl Broman, Andrey Shabalin, Petr Simecek   <https://rdrr.io/bioc/DOQTL/>
  Prism 8.0                                              Graphpad                                                   <https://www.graphpad.com/scientific-software/prism/>
  FlowJo                                                 BD Biosciences                                             <https://www.flowjo.com/>

###### Highlights

-   The Collaborative Cross (CC) models generation of T cell responses of various quantity

-   The CC models generation of qualitatively diverse memory CD8 T cells in response to LCMV

-   QTL mapping reveals candidate genes underlying generation of CD8 T central memory
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